Venture Kick on Twitter: "Smart and personalized brain health gets a boost: TOP 100 Swiss startup @Altoida raises funding and cooperates with strategic investor @Eisai_SDGs from Japan. Congratulations to founder Ioannis Tarnanas
Using augmented reality, Altoida is identifying the likely onset of neurodegenerative diseases | TechCrunch
Ioannis Tarnanas - Worldwebforum
Ιωάννης Ταρνανάς - Έλληνας ερευνητής κέρδισε ΕΙΤ Innovators Award | ellines.com
Ioannis Tarnanas · Founder & Chief Science Officer of Altoida – Fyrfly Venture Partners | fyrfly.vc
Altoida, Inc. - Contacts, Employees, Board Members, Advisors & Alumni
New Alzheimer's Prediction Smartphone App Gets FDA Breakthrough Status - Being Patient
Ioannis Tarnanas Altoida Inc. - PMWC Precision Medicine World Conference
New Alzheimer's Prediction Smartphone App Gets FDA Breakthrough Status - Being Patient
Altoida Raises $6.3 Million for Early, AI-Test for Alzheimer's Disease
Ioannis Tarnanas · Founder & Chief Science Officer of Altoida – Fyrfly Venture Partners | fyrfly.vc
Cognitive Health & Digital Biomarker Technologies | Altoida
Using augmented reality, Altoida is identifying the likely onset of neurodegenerative diseases | TechCrunch
Ioannis Tarnanas | Nature Portfolio Health Community
Dr. Ioannis Tarnanas, Ph.D. - Founder - Altoida, Inc. | LinkedIn
Ioannis Tarnanas, PhD, MSc | Global Brain Health Institute
Greek Researcher Receives Top European Innovation Award (video)
Ioannis Tarnanas - Worldwebforum
Altoida secures funding and research partnership with Eisai Innovation – Venturelab
Ioannis Tarnanas · Founder & Chief Science Officer of Altoida – Fyrfly Venture Partners | fyrfly.vc
Using a Digital Neuro Signature to measure longitudinal individual-level change in Alzheimer's disease: the Altoida large cohort study | npj Digital Medicine
EIT Health - Ioannis Tarnanas is the winner of #EIT Innovators Award. He is CSO for Altoida- makers of ADPS, which can tell if someone will develop Alzheimer's disease within 6 years,
